Stammdaten
Nascent Pharma Holdings, Inc. engages in the protection and commercialization of cannabis patents. It produces superfood drink mix products under the Longevity brand name. The company was formerly known as Can B Corp. and changed its name to Nascent Pharma Holdings, Inc. in September 2025. Nascent Pharma Holdings, Inc. was incorporated in 2005 and is based in Hicksville, New York.
Unternehmen & Branche
| Name | Can B Corp |
|---|---|
| Ticker | NASC |
| CIK | 0001509957 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Drug Manufacturers - Specialty & Generic |
Wertpapier & Kennzahlen
| CUSIP | 13470W103 |
|---|---|
| ISIN | US13470W1036 |
| Typ | Common Stock |
| Marktkapitalisierung | 1,2 Mio. USD |
| Beta | 0,68 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2024-09-30 | 10-Q | 15,269 | -3,262,612 | -0.05 | 1,856,149 | -9,787,641 |
| 2024-06-30 | 10-Q | 272,287 | -2,028,623 | -0.04 | 4,919,929 | -6,752,554 |
| 2024-03-31 | 10-Q | 316,696 | -5,049,933 | -0.13 | 5,322,259 | -5,314,741 |
| 2023-12-31 | 10-K | 2,155,744 | -9,737,464 | -0.77 | 10,126,164 | -1,001,968 |
| 2023-09-30 | 10-Q | 418,957 | -4,165,377 | -0.36 | 13,075,430 | 219,602 |
| 2023-06-30 | 10-Q | 420,593 | -2,027,013 | -0.37 | 14,581,243 | 554,887 |
| 2023-03-31 | 10-Q | 939,305 | -1,739,038 | -0.36 | 15,577,179 | 2,454,236 |
| 2022-12-31 | 10-K | 6,685,519 | -14,924,175 | -4.18 | 15,559,791 | 2,697,925 |
| 2022-09-30 | 10-Q | 2,888,124 | -6,893,976 | -1.98 | 16,718,608 | 4,493,543 |
| 2022-06-30 | 10-Q | 1,271,002 | -1,645,886 | -0.49 | 17,034,584 | 5,639,653 |
| 2022-03-31 | 10-Q | 1,860,320 | -3,484,897 | 16,997,428 | 6,248,194 | |
| 2021-12-31 | 10-K | 4,603,829 | -12,169,395 | 16,474,640 | 5,619,515 | |
| 2021-09-30 | 10-Q | 1,910,372 | -3,232,616 | 14,612,313 | 3,825,943 | |
| 2021-06-30 | 10-Q | 401,766 | -2,739,989 | 6,162,417 | 1,176,679 | |
| 2021-03-31 | 10-Q | 306,940 | -2,179,882 | 6,872,382 | 2,903,693 | |
| 2020-12-31 | 10-K | 1,709,669 | -8,878,904 | -1.36 | 3,911,621 | 1,476,017 |
| 2020-09-30 | 10-Q | 459,496 | -1,233,176 | -0.31 | 6,274,226 | 3,806,328 |
| 2020-06-30 | 10-Q | 205,084 | -1,230,925 | -0.32 | 7,188,614 | 4,944,306 |
| 2020-03-31 | 10-Q | 569,707 | -1,134,107 | 7,139,052 | 5,660,269 | |
| 2017-12-31 | 10-K | 122,746 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.03.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| Byrne Asset Management LLC | 12 | 1 | 100.00 |